suberoyl bis-hydroxamic acid has been researched along with Leukemia, Pre-B-Cell in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shao, N | 1 |
Ma, D | 1 |
Wang, J | 1 |
Lu, T | 1 |
Guo, Y | 1 |
Ji, C | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Leukemia, Pre-B-Cell
Article | Year |
---|---|
Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells.
Topics: Acetylation; Apoptosis; B-Lymphocytes; Cell Division; Cell Line, Tumor; Chromatin Assembly and Disas | 2013 |